SMAD4 and pancreatic intraductal papillary-mucinous neoplasm: In contrast, loss of DPC4 expression can be identified in 16% of invasive carcinomas arising from IPMN, suggesting that SMAD4 mutation is rather a late genetic change in pancreatic carcinogenesis in setting of IPMN.